Medline (MDLN) Liabilities and Shareholders Equity (2024 - 2026)

Medline (MDLN) has 3 years of Liabilities and Shareholders Equity data on file, last reported at $39.0 billion in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity changed N/A year-over-year to $39.0 billion in Q1 2026; TTM through Mar 2026 was $113.5 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $38.5 billion, up 6.97% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $39.0 billion, up from $38.5 billion in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for MDLN reached as high as $39.0 billion in Q1 2026 and fell as low as $36.0 billion in Q4 2024.
• Historically, Liabilities and Shareholders Equity has averaged $37.8 billion across 3 years, with a median of $38.5 billion in 2025.
• On a YoY basis, Liabilities and Shareholders Equity climbed as much as 6.97% in 2025 and fell as far as 6.97% in 2025.
• Year by year, Liabilities and Shareholders Equity stood at $36.0 billion in 2024, then increased by 6.97% to $38.5 billion in 2025, then climbed by 1.38% to $39.0 billion in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $39.0 billion in Q1 2026, $38.5 billion in Q4 2025, and $36.0 billion in Q4 2024.